Antihistamines and driving ability: Evidence from 30 years Dutch on-road driving research
Background: Since all antihistamines are capable of crossing the blood-brain barrier, they may also cause sedation which may impair daily activities such as driving a car. The purpose of this review was to examine the effects of antihistamines on driving ability. Method: A literature search revealed 18 double-blind placebo-controlled clinical trials that applied the on-road highway driving test. In this test, subjects are instructed to drive 100-km on a public highway with a steady lateral position and a constant speed (95 km/h). Primary outcome measure is the Standard Deviation of Lateral Pos... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2015 |
Schlagwörter: | antihistaminic agent / fexofenadine / levocetirizine / triprolidine / placebo / ebastine / diphenhydramine / bilastine / emedastine / clemastine / mizolastine / hydroxyzine / dexchlorpheniramine / mequitazine / cetirizine / terfenadine / loratadine / desloratadine / acrivastine / rupatadine / driving ability / European / allergy / clinical immunology / human / sedation / highway / car / blood brain barrier / single drug dose / controlled clinical trial (topic) / clinical trial (topic) / velocity / recommended drug dose / acute drug administration |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29038380 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://dspace.library.uu.nl/handle/1874/330091 |